Mucormycosis in Indian COVID-19 Patients: Insight into Its Patho-Genesis, Clinical Manifestation, and Management Strategies

Mucormycosis in Indian COVID-19 Patients: Insight into Its Patho-Genesis, Clinical Manifestation, and Management Strategies

Mucormycosis in patients who have COVID-19 or who are otherwise immunocompromised has become a global problem, causing significant morbidity and mortality. Infection is debilitating and fatal, leading to loss of organs and emotional trauma. Radiographic manifestations are not specific, but diagnosis...

Full description

Bibliographic Details
Main Authors: Ram Kumar Sahu, Mounir M. Salem-Bekhit, Bedanta Bhattacharjee, Yosif Almoshari, Abu Md Ashif Ikbal, Meshal Alshamrani, Alakesh Bharali, Ahmad Salawi, Retno Widyowati, Abdulrahman Alshammari, Ibrahim Elbagory
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Antibiotics
Subjects:
COVID-19
mucormycosis
nanoparticles
pathogenesis
amphotericin-B
Online Access:https://www.mdpi.com/2079-6382/10/9/1079

Internet

https://www.mdpi.com/2079-6382/10/9/1079

Similar Items